RecruitingPHASE1, PHASE2NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Studying Bronchial malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IDEAYA Biosciences
- Intervention
- IDE574(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2026 – 2030
Study locations (6)
- START NY, Lake Success, New York, United States
- NEXT Texas LLC - Austin, Austin, Texas, United States
- NEXT Texas LLC - Dallas, Dallas, Texas, United States
- NEXT Texas LLC - Houston, Houston, Texas, United States
- NEXT Texas LLC - San Antonio, San Antonio, Texas, United States
- Start San Antonio, LLC, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07540572 on ClinicalTrials.gov